Supported by independent educational grants from sanofi-aventis, Bristol-Myers Squibb and Medtronic
Resource Center
Slides > Program Slides
-
The Guidelines:How Can They Be Improved? PPT
-
Antiplatelet Therapy for the Prevention of Stroke in AF PPT
-
Initiating Antiplatelet Therapy in ACS: When, Where, and How? PPT
-
Bleeding is the Most Important Prognostic Factor PPT
-
Antiplatelet Therapy Beyond ACS PPT
-
State of the Art Management of ACS: Exploring the Latest Guidelines PPT
-
New Thoughts and Updates on the Changing ACS Environment PPT
-
Antiplatelet Therapy: Where Are We Going? PPT
-
State of the Art Antiplatelet Therapy: How Are We Applying the Evidence in Practice? PPT
-
Bleeding is Just One Prognostic Factor PPT
-
Thienopyridines in PCI: The lowdown on loading doses PPT
